JVT

Risk Consideration for Aging Pharmaceutical Facilities | IVT

A new regulatory consideration has arisen that affects pharmaceutical facilities of a certain vintage: the risks associated with the aging plant. In many more established areas of the world, pharmaceutical facilities are passing various time marks: thirty years, fifty years and even longer. As many pharmaceutical companies seek to establish manufacturing facilities for new product lines in emerging markets (China, Eastern Europe, Asia, for example) some of the more established plants in regions like North America and Europe begin to look older and possibly need more maintenance.

This content is only available to IVT members.
Get help maintaining your knowledge in GMP - Qualification. Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.




Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.